Reina Hara

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Reply.

Reply.

Journal: The journal of allergy and clinical immunology. Global
Published: January 09, 2026

Gastric Aspirate Isolate Demonstrates Strain-Level Concordance With Sputum Isolate in Nontuberculous Mycobacterial Pulmonary Disease.

Gastric Aspirate Isolate Demonstrates Strain-Level Concordance With Sputum Isolate in Nontuberculous Mycobacterial Pulmonary Disease.

Journal: Open forum infectious diseases
Published: November 30, 2025

Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis.

Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis.

Journal: Journal of translational medicine
Published: May 02, 2025

NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.

NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.

Journal: International journal of molecular sciences
Published: January 06, 2025

Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensate.

Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensate.

Journal: The journal of allergy and clinical immunology. Global
Published: September 10, 2024

Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease.

Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease.

Journal: Respiratory research
Published: August 23, 2024

Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine.

Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine.

Journal: International journal of molecular sciences
Published: April 12, 2024

SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis.

SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis.

Journal: JCI insight
Published: November 28, 2023

Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.

Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.

Journal: The Journal of allergy and clinical immunology
Published: April 04, 2023

Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19.

Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19.

Journal: Inflammation and regeneration
Published: October 14, 2022

Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity.

Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity.

Journal: BMC infectious diseases
Published: December 25, 2021

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

Journal: Nature communications
Published: December 14, 2021
Showing 1-12 of 27

Last Updated: 09/26/2026